Loading Page..

Knowledge Content Library

476
Decision Making Under Uncertainty in the Water Sector
By Thomas Chesnutt, San Francisco Chapter Meeting

477
Simulation of the Portfolio of COVID-19 Vaccines
By Vladimir Shnaydman and Jack Scannell, Pharma Interest Group Meeting

473
Impact of Covid-19 Test Reliability
By Brian Putt, San Francisco Chapter Meeting

462
Networked Simulations with Stochastic Libraries
By Sam Savage, San Francisco Chapter Meeting

471
How Can a Board Frame and Manage Cyber Risk
By Mike Jerbic, San Francisco Chapter Meeting

472
Bridging Data Science and Data Quality
By John-Mark Agosta from Microsoft, Brad Powley from Sales Force and Thomas Seyller from Google , San Francisco Chapter Meeting

426
Types of CSRA Models
Group Discussion, Cost and Schedule Risk Analysis Interest Group

421
Calibration in a Cost and Schedule Risk Analysis
Group Discussion, Cost and Schedule Risk Analysis Interest Group

414
Conducting a Cost and Schedule Risk Analysis and Calibration
Group Discussion, Cost and Schedule Risk Analysis Interest Group

417
Types of CSRAs
Group Discussion, Cost and Schedule Risk Analysis Interest Group

418
Why is a CSRA Important
Group Discussion, Cost and Schedule Risk Analysis Interest Group

419
Purpose of CSRA Interest Group
Group Discussion, Cost and Schedule Risk Analysis Interest Group

402
A Scenario-Based Framework for Assessing the Risks of Nuclear Power Plant Accidents
By Dan Hudson, Scenario Analysis Interest Group Presentation

496
A Decision Analytic Approach to Collaboratively Respond to Invasive Grass Carp in Lake Erie
DAS/SDP Practice Award talk by Kelly Robinson, Department of Fisheries and Wildlife, at 2021 DAAG Conference, online.

494
Keynote: Lessons in Decision Making from the Columbia Space Shuttle Accident
Keynote address by Edward Rogers, NASA at 2021 DAAG Conference, online.

450
Case Study: Enhancing Decision Quality by blending Operations Research techniques with classical Decision Analysis
Case Study by Bobby (Gopesh) Rana, Bill Klimack, Chevron at 2019 DAAG Conference in Denver. This talk presents a case study on how to leverage OR and probabilistic DA to channel prescriptive decision analysis.

436
The Metalog Distributions: Flexible, Easy-to-Use, Probability Distributions for Use in Decision Analysis, Modelling, Simulation, and Learning from Empirical Data
Presentation by Tom Keelin, SmartOrg at 2019 DAAG Conference in Denver. In this Life Sciences Mini-Conference. This session is a hands-on, practical introduction to a new tool.

444
Frontiers of DA Talk
Presentation by Tom Keelin, SmartOrg at 2019 DAAG Conference in Denver. A standup chat on the Metalog Distributions, a new probability distribution designed to fit data and of great relevance to Decision Analysts and Data Scientists.

452
Life Sciences Track: Data and Decision Making in Drug Development
Panel discussion with David Wolter, IQVIA; Kirk Solo, Lexidyne Consulting; Thomas Abbott, Real World Informatics; Ian Bonzani, IQVIA at 2019 DAAG Conference in Denver. In this Life Sciences Mini-Conference, this talk covers what data are companies using and what new insights do they find most valuable?

429
Life Sciences Track: Why Do We Need DA When We Have AI?
Panel discussion with Joanna Wolkowski, Pfizer; Julie Schiffman, Pfizer; Leslie Lippard, Genetech; Pratap Khedkar, ZS Associates at 2019 DAAG Conference in Denver. In this Life Sciences Mini-Conference, this talk covers how would DA be used in the future? Will AI eventually replace decision professionals and decision-makers?

Stay connected